213 related articles for article (PubMed ID: 18642030)
1. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.
De Maria S; Pannone G; Bufo P; Santoro A; Serpico R; Metafora S; Rubini C; Pasquali D; Papagerakis SM; Staibano S; De Rosa G; Farina E; Emanuelli M; Santarelli A; Mariggiò MA; Lo Russo L; Lo Muzio L
J Cancer Res Clin Oncol; 2009 Jan; 135(1):107-16. PubMed ID: 18642030
[TBL] [Abstract][Full Text] [Related]
2. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
[TBL] [Abstract][Full Text] [Related]
5. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
6. Survivin, a potential early predictor of tumor progression in the oral mucosa.
Lo Muzio L; Pannone G; Leonardi R; Staibano S; Mignogna MD; De Rosa G; Kudo Y; Takata T; Altieri DC
J Dent Res; 2003 Nov; 82(11):923-8. PubMed ID: 14578507
[TBL] [Abstract][Full Text] [Related]
7. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
Liu YM; Huang JH; Feng DY; Guo XC
Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
[TBL] [Abstract][Full Text] [Related]
8. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis.
Tanaka C; Uzawa K; Shibahara T; Yokoe H; Noma H; Tanzawa H
J Dent Res; 2003 Aug; 82(8):607-11. PubMed ID: 12885844
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.
Shigeishi H; Fujimoto S; Hiraoka M; Ono S; Taki M; Ohta K; Higashikawa K; Kamata N
Int J Oncol; 2009 Jun; 34(6):1565-71. PubMed ID: 19424574
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
[TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
12. ALY as a potential contributor to metastasis in human oral squamous cell carcinoma.
Saito Y; Kasamatsu A; Yamamoto A; Shimizu T; Yokoe H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Apr; 139(4):585-94. PubMed ID: 23242234
[TBL] [Abstract][Full Text] [Related]
13. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma.
Liu S; Shi L; Yang X; Ye D; Wang T; Dong C; Guo W; Liao Y; Song H; Xu D; Hu J; Zhang Z; Deng J
Cell Cycle; 2017 May; 16(9):894-902. PubMed ID: 28384094
[TBL] [Abstract][Full Text] [Related]
14. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
15. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
16. Survivin phosphorylation and M-phase promoting factor in oral carcinogenesis.
Pannone G; Bufo P; Serpico R; Rubini C; Zamparese R; Corsi F; Pedicillo MC; Pannone G; Staibano S; De Rosa G; Lo Muzio L
Histol Histopathol; 2007 Nov; 22(11):1241-9. PubMed ID: 17647197
[TBL] [Abstract][Full Text] [Related]
17. Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer.
Lodi G; Franchini R; Bez C; Sardella A; Moneghini L; Pellegrini C; Bosari S; Manfredi M; Vescovi P; Carrassi A
Oral Dis; 2010 Jan; 16(1):61-7. PubMed ID: 19732355
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD109 in oral squamous cell carcinoma and its clinical significance.
Chen H; Junji Xu ; Ge R; Liu C
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):145-149. PubMed ID: 38814222
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of survivin splicing variants in expression gastric cancer].
Meng H; Dai DJ; Lu CD
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):234-6. PubMed ID: 16167236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
